New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2014
04:55 EDTCYH, CYH, BAX, BAX, CAH, CAH, KND, KND, CRY, CRY, MDCO, MDCO, SRDX, SRDX, XOMA, XOMA, PRGO, PRGO, IDRA, IDRA, EBS, EBS, CVS, CVSRBC Capital to hold a conference
Healthcare Conference is being held in New York on February 25-26.
News For CYH;EBS;IDRA;PRGO;XOMA;SRDX;MDCO;CRY;KND;CAH;BAX;CVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 20, 2014
06:56 EDTPRGOPerrigo files automatic mixed securities shelf
Subscribe for More Information
06:06 EDTMDCOThe Medicines Co. upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
November 19, 2014
20:07 EDTKNDKindred Healthcare 5M share Secondary priced at $19.75
Subscribe for More Information
November 18, 2014
07:37 EDTBAX, IDRAStifel to hold a conference
Subscribe for More Information
07:21 EDTCYHUBS to hold a field trip
Subscribe for More Information
07:01 EDTCYHCommunity Health to divest Mesquite, Texas hosptail
Subscribe for More Information
November 17, 2014
08:37 EDTCAHCardinal Health management to meet with FBR Capital
Meetings to be held in the Midwest November 17-18 hosted by FBR Capital.
07:48 EDTKNDKindred Healthcare files to sell 5M shares of stock and tangible equity units
Kindred Healthcare announced that it has launched concurrent underwritten public offerings of 5,000,000 shares of Kindred's common stock and 150,000 tangible equity units. Each tangible equity unit has a stated amount of $1,000 and is comprised of a prepaid stock purchase contract and a share of mandatory redeemable preferred stock, each issued by the Company. Citigroup Global Markets Inc. and J.P. Morgan Securities LLC are acting as the joint book-running managers for the concurrent offerings.
November 16, 2014
13:41 EDTMDCOThe Medicines Co. presents findings from MDCO-216 study
The Medicines Company presented findings from a new Phase 1 study showing that a single infusion of MDCO-216, an investigational lipid-modifying agent, in both healthy and CAD patients, modified key lipid parameters including ApoA-1, phospholipids, HDL, pre-beta 1 HDL and Apo E, markedly increased ABCA1 mediated efflux, a potential marker of reverse cholesterol transport and was well tolerated. The study was presented today as part of a poster session at The American Heart Association’s Annual Scientific Sessions in Chicago. Clinical findings have shown that human carriers of the ApoA-1 Milano variant have a reduced incidence of cardiovascular disease. MDCO-216, currently under development by The Medicines Company, is a complex of recombinant human Apo A1 with phospholipids to emulate an HDL particle. MDCO-216 has the potential to modify atherosclerotic disease by promoting reverse cholesterol transport, and its potential impact on reducing cardiovascular events in acute coronary syndrome, ACS, patients. “This study provides a signal that MDCO-216 is able to modulate lipid parameters consistent with those humans with the ApoA-1 variant, had an important effect on markers of reverse cholesterol transport such as pre-beta1 HDL and ABCA1 mediated efflux, and importantly was well-tolerated,” commented David Kallend, MBBS, Vice President and Global Medical Director for the Lipid Programs at The Medicine Company. “These findings support the continued development of MDCO-216 as a potential treatment to help address a currently unmet need in coronary artery disease patients."
November 14, 2014
14:53 EDTCVSCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
10:33 EDTMDCOThe Medicines Co. to present new data on MDCO-216 at AHA sessions
Subscribe for More Information
November 12, 2014
12:11 EDTCYHWells Fargo sees headwinds for hospitals, downgrades HCA, Community Health
Subscribe for More Information
10:00 EDTCYHOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:01 EDTCYHNurses expected to protest, strike over Ebola protection, Reuters says
Subscribe for More Information
08:04 EDTSRDXSurModics announce $20M accelerated share repurchase program
Subscribe for More Information
08:02 EDTBAXCredit Suisse to hold a conference
Subscribe for More Information
08:01 EDTKNDKindred Healthcare to acquire Centerre Healthcare for $195M in cash
Kindred Healthcare announced that it has signed a definitive merger agreement to acquire Centerre Healthcare Corporation, a national company dedicated to operating Inpatient Rehabilitation Hospitals, for a purchase price of approximately $195M in cash. Centerre currently operates 11 Inpatient Rehabilitation Hospitals with 612 beds in partnership with some of the nation’s leading acute care hospital systems through joint ventures. Centerre has two additional hospitals with a total of 90 beds under construction and scheduled to open in 2015, and a pipeline of additional potential hospitals in various stages of development.
07:27 EDTBAXNorth American Spine Society to hold annual meeting
Subscribe for More Information
05:32 EDTCYHHospital sector downgraded to Market Weight at Wells Fargo
Wells Fargo downgraded the Hospital group to Market Weight from Overweight saying the Supreme Court's decision to hear the King v. Burwell case as well as the government's reduced expectations for exchange enrollment in 2015 are likely to remain an overhang on the sector through at least the end of June. Along with the group cut, Wells downgraded shares of HCA Holdings (HCA) and Community Health (CYH) to Market Perform from Outperform. The firm keeps Market Perform ratings on Acadia (ACHC), LifePoint Hospitals (LPNT), Tenet (THC) and Universal Health (UHS).
05:28 EDTCYHCommunity Health downgraded to Market Perform from Outperform at Wells Fargo
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use